Haloperidol Lactate Injection Recalled for Incorrect RFID Tags
Safecor Health recalled Haloperidol Lactate Injection due to incorrect RFID tag serial numbers applied during repackaging. The error affects 800 vials distributed in Massachusetts.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA classified this as a Class II recall for a labeling error. The hazard is limited to incorrect RFID tracking tags on otherwise intact pharmaceutical product, with no explicit report of illnesses or injuries.
Plain-English summary
Safecor Health, LLC is recalling Haloperidol Lactate Injection, 5 mg/mL in single-dose vials (NDC 67457-426-12) due to incorrect RFID tag labels applied during repackaging. The repackaging firm applied KITCHECK RFID tags bearing incorrect serial numbers.
The incorrect labeling affects 800 vials from Lots 25381993 and 25391516 (expiration 12/31/2026) that were distributed in Massachusetts. The issue was identified and reported to the FDA as a Class II recall.
Recipients of affected vials should verify the RFID tag serial numbers on their inventory. The drug product itself is not defective; the error is limited to the tracking labels. Contact Safecor Health, LLC for further instructions regarding affected product.
The recalled product
- Product
- HALOPERIDOL LACTATE (HALOPERIDOL LACTATE)
- Brand
- HALOPERIDOL LACTATE
- Manufacturer
- Safecor Health, LLC
- Category
- Drug — Injectable Antipsychotic
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 25381993 and 25391516
- Exp 12/31/2026
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27